Zoratral Xr

Zoratral XR contains Alfuzosin Hydrochloride, a selective alpha-blocker used to improve urine flow in men with enlarged prostate symptoms. This extended-release formulation provides steady symptom relief throughout the day. Ideal for managing benign prostatic hyperplasia (BPH) with minimal dosing frequency.

Alfuzosin Hydrochloride, the active ingredient in Zoratral XR, is commonly prescribed to relieve symptoms associated with an enlarged prostate, such as difficulty urinating, frequent urination, or weak urine stream. It works by relaxing the muscles in the prostate and bladder neck, making it easier to pass urine. This medication is not a cure but helps manage ongoing symptoms.

Users of Zoratral XR often notice improved urine flow and reduced urgency shortly after starting treatment. Some may experience a decrease in nighttime bathroom trips, leading to better sleep quality. Mild side effects like dizziness or fatigue can occur, especially when first beginning the medication.

Zoratral XR should be taken exactly as prescribed, preferably after the same meal each day to maintain consistent blood levels. Avoid sudden position changes, such as standing up quickly, to reduce the risk of dizziness. Inform your healthcare provider about any history of low blood pressure or liver problems before use.

Alcohol and other medications that lower blood pressure may increase the risk of dizziness or fainting when taken with Zoratral XR. Strong CYP3A4 inhibitors, such as certain antifungals or antibiotics, can raise Alfuzosin levels in the blood, so caution is advised. Always review your current medications with a healthcare professional before starting this treatment.